Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Masuda, Norihiko"'
Autor:
Masuda, Norihiko
乙第13466号
論医博第2253号
新制||医||1055(附属図書館)
学位規則第4条第2項該当
Doctor of Medical Science
Kyoto University
DFAM
論医博第2253号
新制||医||1055(附属図書館)
学位規則第4条第2項該当
Doctor of Medical Science
Kyoto University
DFAM
Externí odkaz:
http://hdl.handle.net/2433/267954
Autor:
Masuda, Norihiko, Murakami, Kaoru, Kita, Yuki, Hamada, Akihiro, Kamada, Mayumi, Teramoto, Yuki, Sakatani, Toru, Matsumoto, Keiyu, Sano, Takeshi, Saito, Ryoichi, Okuno, Yasushi, Ogawa, Osamu, Kobayashi, Takashi
Publikováno v:
In The American Journal of Pathology August 2020 190(8):1752-1762
Autor:
MAKITA, Noriyuki, MURASHIMA, Takaya, MASUDA, Norihiko, NISHIKAWA, Nobuyuki, SOHMA, Takahito, SEGAWA, Takehiko
Publikováno v:
泌尿器科紀要. 69(3):91-95
An 85 year-old man was referred to our hospital because of a relapse of abscess after open surgical drainage of the right scrotum. Computed tomography (CT) showed fluid accumulation in the right scrotum and around the membranous urethra. The abscess
Autor:
Sunada, Takuro, Hama, Yusuke, Ikeuchi, Ryosuke, Funada, Satoshi, Masuda, Norihiko, Yoshikawa, Takeshi, Yoshida, Toru, Hataya, Yuji, Komatsu, Yasato, Segawa, Takehiko
Publikováno v:
泌尿器科紀要. 64(12):501-504
We report a 60-year-old man with prostate cancer diagnosed during androgen replacement therapy (ART) for late onset hypogonadism after surgery for pituitary adenoma. He was refered to the department of urology since prostate specific antigen values w
Autor:
Hayata, Naoki, Yoshida, Toru, Hama, Yusuke, Sunada, Takuro, Masuda, Norihiko, Yoshikawa, Takeshi, Satogami, Naoe, Segawa, Takehiko
Publikováno v:
泌尿器科紀要. 64(12):483-487
Randomized phase III trials demonstrated superiority of targeted therapy with tyrosine kinase inhibitors over cytokine-based therapy as first-line therapy for metastatic renal cell carcinoma. However, the rate of complete response (CR) with targeted
Autor:
Ohsugi, Haruyuki, Kitamura, Yuki, Manabe, Yumi, Masuda, Norihiko, Ito, Haruki, Mishina, Mutsuki, Okuno, Hiroshi
Publikováno v:
泌尿器科紀要. 60(8):375-379
Intravesical chemotherapy is beneficial for patients with non-muscle-invasive bladder cancer (NMIBC), but optimal drug and regimen selection can be controversial. Mitomycin C (MMC) is commonly used as adjuvant treatment for NMIBC. We retrospectively
Autor:
Kono, Yuka, Matsumoto, Keiyu, Masuda, Norihiko, Shiraishi, Yusuke, Negoro, Hiromitsu, Utsunomiya, Noriaki, Tsunemori, Hiroyuki, Okubo, Kazutoshi, Okada, Takuya, Segawa, Takehiko, Muguruma, Koei, Kawakita, Mutsushi
Publikováno v:
泌尿器科紀要. 60(2):57-60
We assessed the safety, and postoperative urinary status of holmium laser enucleation of the prostate (HoLEP) for the treatment of benign prostatic hyperplasia (BPH). Of the initial 117 patients who underwent HoLEP from November 2004 to March 2011, 4
Autor:
Utsunomiya, Noriaki, Kono, Yuka, Matsumoto, Keiyu, Sumiyoshi, Takayuki, Masuda, Norihiko, Shiraishi, Yusuke, Negoro, Hiromitsu, Tsunemori, Hiroyuki, Sugino, Yoshio, Okubo, Kazutoshi, Okada, Takuya, Segawa, Takehiko, Muguruma, Koei, Kawakita, Mutsushi
Publikováno v:
泌尿器科紀要. 60(1):1-5
The TNM classification of renal cell carcinoma was updated in 2009. In this new classification system, T3a consists of tumors with renal vein involvement and tumors with fat invasion. To assess risk factors for recurrence, we retrospectively reviewed
Autor:
Kitamura, Yuki, Okuno, Hiroshi, Sakura, Yuma, Manabe, Yumi, Masuda, Norihiko, Ito, Haruk, Mishina, Mutsuki, Taoka, Rikiya, Terai, Akito, Sugimoto, Mikio, Kakehi, Yoshiyuki
Publikováno v:
泌尿器科紀要. 60(1):17-23
In Japan, prostate cancer is treated with non-steroidal anti-androgen (flutamide and bicalutamide). Development of breast pain during bicalutamide treatment, in prostate cancer patients reduces their quality of life (QOL) and treatment compliance. We